12:00 AM
Jun 15, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ondansetron regulatory update

FDA accepted for filing an NDA from Par's Strativa Pharmaceuticals unit for an ondansetron orally dissolving film strip to prevent nausea and vomiting associated...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >